Literature DB >> 10544298

Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth.

K Mitsumori1, A Terai, H Oka, T Segawa, K Ogura, O Yoshida, O Ogawa.   

Abstract

BACKGROUND: The androgen receptor (AR) gene has a polymorphic CAG microsatellite encoding variable-length glutamine repeats in the AR protein. The purpose of this study was to evaluate the association between the growth of benign prostatic hyperplasia (BPH) and the AR gene CAG repeat length.
METHODS: We determined CAG repeat lengths in 176 BPH patients who underwent simple prostatectomy and in 41 control subjects without benign prostatic enlargement (non-BPE group).
RESULTS: A statistically significant (P < 0.02) trend for large adenoma size with short CAG repeat length was found among the adenoma quartiles. CAG repeat length in the fourth quartile (large adenoma, 21.5 +/- 2.7) was significantly shorter than in the first quartile (small adenoma, 23.3 +/- 2.1, P < 0.02). It tended to be shorter than in the non-BPE group (23.1 +/- 2.4), but CAG repeat lengths in the entire BPH (22.4 +/- 2.5) and non-BPE groups did not significantly differ. The relative risk of large BPH (the fourth quartile) was 2.75 (95% confidence interval, 1.05-7.24; P < 0.05) on comparing CAG repeats of < or = 22-> or = 23.
CONCLUSIONS: Shorter CAG alleles may be a genetic factor that promotes the growth of BPH. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544298     DOI: 10.1002/(sici)1097-0045(19991201)41:4<253::aid-pros5>3.0.co;2-9

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

Review 1.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 2.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

3.  Polymorphisms in the MLL breakpoint cluster region (BCR).

Authors:  Deborah R Echlin-Bell; Lydia L Smith; Loretta Li; Pamela L Strissel; Reiner Strick; Vandana Gupta; Jhula Banerjee; Richard Larson; Mary V Relling; Susan C Raimondi; Yasuhide Hayashi; Tomohiko Taki; Nancy Zeleznik-Le; Janet D Rowley
Journal:  Hum Genet       Date:  2003-03-29       Impact factor: 4.132

4.  Androgen receptor trinucleotide polymorphism in leiomyoma.

Authors:  Yao-Yuan Hsieh; Chi-Chen Chang; Fuu-Jen Tsai; Cheng-Chieh Lin; Lian-Shun Yeh; Ching-Tien Peng
Journal:  J Assist Reprod Genet       Date:  2004-12       Impact factor: 3.412

5.  Polymorphisms in the vitamin D receptor and the androgen receptor gene associated with the risk of urolithiasis.

Authors:  Rama Devi Mittal; D K Mishra; P Srivastava; P Manchanda; H K Bid; R Kapoor
Journal:  Indian J Clin Biochem       Date:  2010-05-27

Review 6.  Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence.

Authors:  Kitty Kit Ting Cheung; Andrea On Yan Luk; Wing Yee So; Ronald Ching Wan Ma; Alice Pik Shan Kong; Francis Chun Chung Chow; Juliana Chung Ngor Chan
Journal:  J Diabetes Investig       Date:  2014-11-03       Impact factor: 4.232

Review 7.  Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.

Authors:  Rufus Cartwright; Altaf Mangera; Kari A O Tikkinen; Prabhakar Rajan; Jori Pesonen; Anna C Kirby; Ganesh Thiagamoorthy; Chris Ambrose; Juan Gonzalez-Maffe; Phillip R Bennett; Tom Palmer; Andrew Walley; Marjo-Riitta Järvelin; Vik Khullar; Chris Chapple
Journal:  Eur Urol       Date:  2014-01-22       Impact factor: 20.096

Review 8.  Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action.

Authors:  Giacomo Tirabassi; Angelo Cignarelli; Sebastio Perrini; Nicola Delli Muti; Giorgio Furlani; Mariagrazia Gallo; Francesco Pallotti; Donatella Paoli; Francesco Giorgino; Francesco Lombardo; Loredana Gandini; Andrea Lenzi; Giancarlo Balercia
Journal:  Int J Endocrinol       Date:  2015-09-02       Impact factor: 3.257

9.  Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.

Authors:  Su Kang Kim; Hyun Kyung Park; Han Sung Choi; Koo Han Yoo; Joo-Ho Chung
Journal:  Int Neurourol J       Date:  2016-12-26       Impact factor: 2.835

10.  Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample.

Authors:  Richard Berges; Andrea Gsur; Elisabeth Feik; Klaus Höfner; Theodor Senge; Ludger Pientka; Andreas Baierl; Martin C Michel; Anton Ponholzer; Stephan Madersbacher
Journal:  World J Urol       Date:  2009-11-17       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.